Inhibikase Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| SANDS FRANK M. | — | Purchase | 2,068,965 | $1.45 | $2,999,999 | 13,018,965 | Nov 21, 2025 |
| Munshi Amit | — | Award / Grant | 57,265 | — | — | 57,265 | Feb 21, 2025 |
| Bellini Roberto | — | Purchase | 1,460,000 | $1.37 | $2,000,200 | 1,460,000 | Oct 21, 2024 |
| Kush Arvind | — | Purchase | 145,000 | $1.37 | $198,650 | 145,000 | Oct 21, 2024 |
| Munshi Amit | — | Purchase | 365,000 | $1.37 | $500,050 | 365,000 | Oct 21, 2024 |
| Werner Milton H. | President and CEO | Purchase | 5,000 | $0.80 | $4,000 | 5,335,433 | Aug 16, 2022 |
| Werner Milton H. | President and CEO | Purchase | 5,000 | $0.98 | $4,900 | 5,330,433 | May 27, 2022 |
| Werner Milton H. | President and CEO | Purchase | 10,000 | $0.60 | $6,000 | 5,325,433 | May 20, 2022 |
| FRATTAROLI JOSEPH | Chief Financial Officer | Purchase | 3,948 | $0.64 | $2,527 | 48,091 | May 19, 2022 |
| Werner Milton H. | President and CEO | Option Exercise | 21,853 | $2.02 | $44,143 | 5,315,433 | Jan 3, 2022 |
| Werner Milton H. | President and CEO | Purchase | 1,100 | $1.97 | $2,167 | 23,589 | Nov 17, 2021 |
| Werner Milton H. | President and CEO | Option Exercise | 21,853 | $2.02 | $44,143 | 5,293,580 | Aug 17, 2021 |
| Werner Milton H. | President and CEO | Tax Withholding | 16,918 | $4.59 | $77,654 | 5,271,727 | May 14, 2021 |
| FRATTAROLI JOSEPH | Chief Financial Officer | C | 44,143 | $10.00 | $441,430 | 44,143 | Dec 28, 2020 |